Skip to content

Interest in Clonidine in Association With Levobupivacaine Performing a Pudendal Block in Proctological Surgery.

Interest in Clonidine in Association With Levobupivacaine Performing a Pudendal Block in Proctological Surgery: Pilot Study, Prospective

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04530903
Enrollment
30
Registered
2020-08-28
Start date
2020-09-09
Completion date
2021-01-01
Last updated
2020-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Proctological Surgery

Keywords

Post-operative Pain, Pudendal Block, Clonidine, Levobupivacaine

Brief summary

Proctological surgery represents a short duration surgery performed in ambulatory, which causes significant post-operative pain. Post-operative pain resulting from proctological surgery is greater than 5 on the Visual Analog Scale (VAS) within the first 24 hours and it revives during the first defecation. The ideal pain management procedures are based on the multimodal analgesia model, based in turn on the combination of products and / or techniques to improve the quality of analgesia, reduce the side effects linked to the use of opioids, reduce responses to surgical stress, reduce postoperative recovery and allow rapid rehabilitation of the patient. The aim of our study is to investigate whether clonidine combined with levobupivacaine in the pudendal block reduce the total consumption of opioids in proctological surgery.

Interventions

DRUGClonidine

75 µg (0.5mL) per injection site

DRUGLevobupivacaine

0.25% (10 ml) per injection site

DRUGNaCl 0.9%

Nacl 0.9% (0.5ml) per injection site

Sponsors

Centre Hospitalier Universitaire Saint Pierre
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18 years * Signature of informed consent

Exclusion criteria

* Refusal to participate ; * Allergy to either local anaesthetics or clonidine; * Local infectious pathologies (e.g. acute ano-perineal suppuration) * Pregnancy * Breastfeeding * Severe bradyarrhythmia due to sinus node disease or second and third degree atrioventricular block * Severe depressive condition * Severe coronary artery disease * Raynaud's disease * Heart failure * Obliterating thromboangiitis * Epilepsy * Spinal anesthesia

Design outcomes

Primary

MeasureTime frameDescription
Total Dose of Opioids consumed in the intraoperative periodup to 24 hours post-surgeryTotal consumption of sufentanyl during the intraoperative period (in micrograms). The administration of sufentanyl depends on the change of physiological parameters (augmentation of 20% of blood pressure and/or cardiac frequency).

Secondary

MeasureTime frameDescription
Total consumption of tramadol in post-operative periodup to 24 hours post-surgeryTotal consumption of tramadol from the exit of the recovery room to the day after the surgery based on Visual Analogic Pain Score \>4 (scale = 0 no pain; 10 = worst pain imaginable). Tramadol (dose in milligrams, oral administration)
Need for tramadol administration per patient during the first 24 hoursup to 24 hours post-surgeryNumber of Tramadol dose requested by the patient during the first 24 hours
Total Dose of piritramide consumed in the recovery roomup to 24 hours post-surgeryIn the recovery room, dose of piritramide (in milligrams, intravenous administration). The administration of piritramide depends on Visual Analogic Pain Score (VAS\>4) (scale = 0 no pain; 10 = worst pain imaginable)
Need for Piritramid administration per patient during the hospitalization in Post Anesthesia Care Unit (PACU)during the hospitalization in Post Anesthesia Care Unit (PACU)Number of Piritramid dose requested by the patient during the hospitalization in Post Anesthesia Care Unit (PACU)
Total Dose of tramadol consumed in the recovery roomup to 24 hours post-surgeryIn the recovery room, dose of tramadol (in milligrams, intravenous administration). The administration of tramadol depends on Visual Analogic Pain Score (VAS\>4) (scale = 0 no pain; 10 = worst pain imaginable)
Total consumption of diclofenac in post-operative periodup to 24 hours post-surgeryTotal consumption of diclofenac from the exit of the recovery room to the day after the surgery based on Visual Analogic Pain Score \>4 (scale = 0 no pain; 10 = worst pain imaginable). Diclofenac (dose in milligrams, oral administration)
Time before First Use of Rescue Analgesicup to 24 hours post-surgeryTime between the completion of the block and the first post-operative administration of rescue analgesics (Tramadol and/or Piritramide on request)
Post-operative Pain as assessed by Visual Analog Scaleup to 24 hours post-surgeryPost-operative Pain levels will be determined every 15 minutes in the recovery room, then every hour until discharge and on Day 1 at home; Visual Analog pain score (scale = 0 no pain; 10= worst pain imaginable)
Patient satisfactionup to 24 hours post-surgeryLevel of satisfaction assessed on a 5-point scale (from 1 to 5): 1 not satisfied, 2 not very satisfied, 3 moderately satisfied, 4 satisfied, 5 very satisfied.
Total consumption of paracetamol in post-operative periodup to 24 hours post-surgeryTotal consumption of paracetamol from the exit of the recovery room to the day after the surgery based on Visual Analogic Pain Score \>4 (scale = 0 no pain; 10 = worst pain imaginable). Paracetamol (dose in grams, oral administration)

Countries

Belgium

Contacts

Primary ContactPanayota Kapessidou, MD,PhD
pkapessi@ulb.ac.be+32.2.535
Backup ContactMyriam Suball, MD
myriam_suball@stpierre-bru.be+32.2.535

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026